The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current earnings (TTM) are $7.72 B. In 2021 the company made an earning of $7.89 B a decrease over its 2020 earnings that were of $9.39 B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | $7.72 B | -2.18% |
2021 | $7.89 B | -15.93% |
2020 | $9.39 B | -9.9% |
2019 | $10.42 B | -4.66% |
2018 | $10.93 B | 0.33% |
2017 | $10.90 B | 4.59% |
2016 | $10.42 B | 14.88% |
2015 | $9.07 B | 36.31% |
2014 | $6.65 B | 5.87% |
2013 | $6.28 B | 3.71% |
2012 | $6.06 B | 31.44% |
2011 | $4.61 B | -22.11% |
2010 | $5.92 B | 3.35% |
2009 | $5.72 B | 9.88% |
2008 | $5.21 B | 9.1% |
2007 | $4.77 B | -22.57% |
2006 | $6.17 B | 27.31% |
2005 | $4.84 B | 24.25% |
2004 | $3.90 B | 26.22% |
2003 | $3.09 B | -66.76% |
2002 | $9.29 B | 507.32% |
2001 | $1.53 B |